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a b s t r a c t
Three phage-displayed peptides designated H, S and F that recognize porcine aminopeptidase N (pAPN),
the cellular receptor of porcine transmissible gastroenteritis virus (TGEV) were able to inhibit cell
infection by TGEV. These same peptides had no inhibitory effects on infection of Vero cells by porcine
epidemic diarrhea virus (PEDV). However, when PEDV, TGEV and porcine pseudorabies virus were
incubated with peptide H (HVTTTFAPPPPR), only infection of Vero cells by PEDV was inhibited.
Immunoﬂuoresence assays indicated that inhibition of PEDV infection by peptide H was independent
of pAPN. Western blots demonstrated that peptide H interacted with PEDV spike protein and that pre-
treatment of PEDV with peptide H led to a higher inhibition than synchronous incubation with cells.
These results indicate direct interaction with the virus is necessary to inhibit infectivity. Temperature
shift assays demonstrated that peptide H inhibited pre-attachment of the virus to the cells.
& 2014 Published by Elsevier Inc.
Introduction
Coronaviruses belong to the family of Coronaviridae and commonly
cause respiratory or gastroenteric diseases (Weiss and Navas-Martin,
2005; Lai et al., 2007). Three groups of coronaviruses have been
identiﬁed, based on differences in serology and genotyping (Cavanagh,
1997; Spaan et al., 2005). These are enveloped viruses and consist of
four major structural proteins: spike (S), membrane (M), nucleocapsid
(N) and minor small envelop (E) protein (Lai et al., 2007).
The host range and tissue tropism of coronaviruses depend on
interactions between the viral S glycoprotein and receptors on
susceptible cells (Bosch et al., 2003; Gallagher and Buchmeier, 2001).
Porcine transmissible gastroenteritis virus (TGEV) and porcine
epidemic diarrhea virus (PEDV) are swine-speciﬁc enteric corona-
viruses that are antigenically distinguishable (Lai et al., 2007;
Pensaert and Yeo, 2006). However, they replicate in the differen-
tiated enterocytes of the small intestine resulting in similar clinical
symptoms including lethal watery diarrhea and dehydration in
piglets (Pensaert and Yeo, 2006; Sanchez et al., 1992). Two decades
ago, porcine aminopeptidase N (pAPN) was identiﬁed as a cellular
receptor for TGEV (Delmas et al., 1992). Since that time, several
limited reports have showed that addition of exogenous pAPN
facilitates cell infection by PEDV (Li et al., 2007; Oh et al., 2003.).
Recent evidence also indicates that increased pAPN receptor density
on the surface of ST cells contributes to cell infection by PEDV (Nam
and Lee, 2010). The available data supports the hypothesis that
blockage of pAPN is a good strategy for preventing cell infection by
TGEV or PEDV. Using the pAPN as a target protein, we identiﬁed
three 12-mer peptides (designated as H, S or F) by phage display
which bind to pAPN and competitively inhibit cell infection by
TGEV (Ren et al., 2011a).
The initial purpose of this study was to investigate the role of
pAPN-binding peptides H, S and F on cell infection by PEDV.
Interestingly, although there was no surface expression of pAPN on
Vero cells, peptide H decreased the infectivity of PEDV in vitro.
Western blots indicated that peptide H (HVTTTFAPPPPR) inter-
acted with the S protein of PEDV. Altering incubation temperatures
further demonstrated that peptide H affected pre-attachment of
PEDV to cells. It is important to identify small molecules such as
peptides that prevent infection by PEDV, inasmuch as highly
effective PEDV vaccines which are currently not available.
The peptide H identiﬁed herein may be one such candidate.
Results
Cytotoxicity of peptides H, S and F in Vero cells
The cytotoxicities of peptides H, S and F were evaluated by the
MTT assay. The CC50 was calculated and deﬁned as the critical
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concentration of compound that decreased the percentage of
formazan produced in uninfected, peptide-treated cells to 50% of
that produced in uninfected, peptide-free cells. The CC50 values
were greater than 1000 μg/ml. All subsequent antiviral experi-
ments were performed at peptide concentrations below the
experimentally-determined CC50 value.
Inhibitory effect of peptides H, S and F on PEDV infection of Vero cells
In order to test the abilities of the three peptides to prevent
attachment of PEDV to cells, all combinations of peptide, virus and
cell treatment were performed. Cell post-treatment assays
(Fig. 1A) were performed to evaluate whether the three peptides
were able to inhibit replication of PEDV after infecting Vero cells.
Plaque assays indicated that none of the three peptides inhibited
PEDV infection; however, rabbit anti-PEDV decreased vial infectiv-
ity by more than 50% when the dilutions were reduced from 1:64
to 1:4. When Vero cells were pre-treated with peptide (cell pre-
treatment assay) prior to virus infection (Fig. 1B), little changes in
virus titers were observed between the control and peptide
treatment groups; some small effects were observed with the
rabbit anti-PEDV neutralizing antibodies. Finally, in the virus pre-
treatment assays where PEDV was incubated with peptides prior
to cell infection (Fig. 1C), the results indicated that both peptides H
and S inhibited PEDV infectivity where EC50 values were approxi-
mately 1 μg/ml and 62.5 μg/ml, respectively. The antiviral activity
of peptide H was dose-dependent and at 250 μg/ml it exhibited
greater than 95% anti-PEDV activity which is signiﬁcantly higher
than peptides S or F (po0.01); at 15.6 μg/ml, inhibition was
greater than 70%. The Selectivity indices SI of peptides H and
S were 1000 and 16, respectively. Peptide F showed little inhibi-
tory activity against PEDV infection even at concentrationsZ
1000 μg/ml.
IFA analysis of pAPN expression on Vero cells
Inasmuch as pAPN may be involved in cell infection by PEDV,
the existence of pAPN on ST, Vero and MDCK cells was analyzed by
IFA. As shown in Fig. 2, the endogenous pAPN expressed only on
the surface of ST cells, a porcine cell line. No expression was found
on the surfaces of Vero cells or MDCK cells suggesting that the
inhibitory activity of peptide H on PEDV infection in vitro did not
involve pAPN.
Peptide H speciﬁcally inhibits PEDV
The speciﬁcity of the inhibition of peptide H on PEDV infection
was assessed by comparing antiviral activities of peptide H on
TGEV and PrV. Further, peptide-induced cytotoxicity in ST cells
was also evaluated. Results clearly show that peptide H had no
demonstrable effects on TGEV or PrV even at very high peptide
concentrations (1 mM/ml) (Fig. 3) suggesting that a non-speciﬁc
reactivity with virus envelopes is unlikely to be the cause for
attenuating PEDV infectivity.
Semi-quantitative real-time RT-PCR
The effect of peptide H on the level of virus RNA was quantiﬁed
by real-time RT-PCR. The results demonstrated a dose-dependent
decrease of viral RNA synthesized in PEDV-infected cells (Fig. 4).
At 31.25 μg/ml and 15.625 μg/ml, peptide H showed reduction of
viral RNA synthesis (po0.05). However, at 250 μg/ml, 125 μg/ml
and 62.5 μg/ml it signiﬁcantly decreased viral RNA synthesis
(po0.01) when compared to the no peptide treatment group.
The inhibitory activity of peptide H against PEDV infection was
conﬁrmed by conventional RT-PCR. Analysis of the PEDV-RNAs
indicated that the density of the ampliﬁed sequences decreased
with increasing concentrations of peptide H (data not shown).
Binding of peptide H to the spike protein of PEDV
Binding characteristics of the phage H (phage encoding pep-
tide H) to PEDV was analyzed by Western blot. As shown in Fig. 5,
the phage H reacted with a protein with an approximate molecular
mass of 220 kDa which is coincident with the molecular mass of
the PEDV S protein. Antibody against the PEDV S protein was used
as a positive control. Other controls including the M13 phage
library and two phages bearing non-selected peptides did not
react with the PEDV S protein (Fig. 5). These results indicate that
the peptide H binds to the S protein of PEDV.
Peptide H inhibits pre-attachment of PEDV
To further examine the mechanism of action of peptide H on
cell infection by PEDV, we investigated the effects of incubation
temperature on cell infectivity. Plaque assays showed that peptide
Fig. 1. Inhibition of pAPN-recoginzing peptides on cell infection by PEDV. (A) PEDV
(PFU¼5103/ml) was ﬁrst incubated with Vero cells at 37 1C for 1 h, followed by
the addition of various concentrations of peptides H, S or F. (B) Vero cells were
incubated with various concentrations of peptides H, S or F at 37 1C for 1 h, then
infected with PEDV at an PFU of 5103/ml. (C) Peptides H, S or F were ﬁrst
incubated with PEDV at 37 1C for 1 h, and then the peptide treated viruses
(PFU¼5103/ml) were used to infect Vero cells at 37 1C. Plaque assays were
performed at the end of each experiment. Serially-diluted polyclonal antibody
against PEDV and PBS were used as positive and negative controls, respectively.
Peptide concentrations 1, 2, 3, 4, and 5 are 250 μg/ml, 125 μg/ml, 62.5 μg/ml,
31.25 μg/ml, and 15.625 μg/ml, respectively. Anti-PEDV antibody dilutions 1, 2, 3, 4,
and 5 are 1:4, 1:8; 1:16; 1:32; and 1:64, respectively. Bars show the standard
deviation from three independent assays.
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H exhibited signiﬁcantly higher inhibitory effects (po0.01) than
peptide F or PBS on the pre-attachment of PEDV to Vero cells
(Fig. 6A) when virus was incubated with peptide H at 4 1C for 1 h
prior to incubation with the cells. When peptide H and PEDV were
co-incubated with Vero cell at 4 1C for 1 h before shifting to 37 1C
(binding only), this allowed us to measure peptide H effects on
early- and pre-attachment of the virus. Results showed that PEDV
pre-treated with peptide H exhibited slightly higher inhibition
(p40.05) than when peptide H and PEDV were co-incubated with
cells absent a pre-incubation step (Fig. 6B) suggesting that there is
a direct effect of peptide H on pre-attachment. Little to no
inhibition of infection was observed once the virus became
attached to the cell surface. Furthermore, when the peptides and
PEDV were co-incubated with Vero cells at 37 1C absent any pre-
incubation step, no effective inhibition of cell infection was
observed (Fig. 6C).
Fig. 2. Indirect immunoﬂuorescence of pAPN on different cell lines. ST, Vero and MDCK cells were incubated with anti-pAPN antibody followed by FITC-conjugated goat
anti-rabbit IgG. Fluorescence images are provided along with representative phase contrast images.
Fig. 3. Inhibitory speciﬁcity of peptide H. Peptide H was incubated with the TGEV,
PEDV and PrV at 37 1C for 1 h followed by infection of susceptible cells and plaque
assays. The concentrations and reductions in virus titers are indicated. Peptide
concentrations 1, 2, 3, 4, and 5 are 250 μg/ml, 125 μg/ml, 62.5 μg/ml, 31.25 μg/ml,
and 15.625 μg/ml, respectively. Bars show the standard deviation from three
independent assays.
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To characterize the temperature effect on interactions between
peptide H and PEDV as well as cell infection, various concentra-
tions of the peptides were incubated with PEDV (PFU¼5103/ml)
at 4 1C or 37 1C for 1 h, then the peptide-treated viruses were used
to infect cells at 37 1C. The results showed that the inhibition rate
at 37 1C was signiﬁcantly higher (po0.01) than that at 4 1C when
the lower concentrations of peptide H were applied. The inhibition
ratio reached 61.86% at 37 1C but only 1.25% at 4 1C at the lowest
concentration (15.625 μg/ml). In contrast, high concentrations of
peptide H gave rise to a similar inhibition of PEDV infectivity
(Fig. 6D).
Discussion
Infection with TGEV and PEDV can cause high mortality in
piglets and therefore enormous economic loss in the pig industry.
The prevalence of PEDV and TGEV in Asian countries such as China
and Korea has been documented (Ren et al., 2011b; Li and
Ren, 2011). At present, live vaccines against the both viruses are
extensively used in China which in turn decreases the occurrence
of diseases to some extent. However, small molecule inhibitors to
TGEV or PEDV are alternative approaches to controlling swine viral
diarrhea diseases.
Using combinatorial phage-display peptide libraries can be a
powerful tool for selecting ligands that bind target proteins. Phage
display techniques have been used to generate diagnostic and
therapeutic peptides for bacteria (Bishop-Hurley et al., 2005, 2010;
Carnazza et al., 2008), fungi (Bishop-Hurley et al., 2002; Fang et al.,
2006) and viruses (Ren et al., 2011a, 2010; Ferrer and Harrison,
1999; Welch et al., 2007; Wu et al., 2011; Yang et al., 2003).
The pAPN is a member of a membrane-bound metalloprotease
family and predominantly expressed on the surface of epithelial
cells of the kidney, small intestine, and respiratory tract (Nam and
Lee, 2010; Kenny and Maroux, 1982; Lendeckel et al., 2000). It is
known that pAPN is a cellular receptor for TGEV and that anti-
pAPN antibody efﬁciently decreases cell infection by this virus
(Delmas et al., 1992; Liu et al., 2009). Recently, three pAPN-binding
peptides H, S, and F were identiﬁed using pAPN as an immobilized
target for panning a 12-mer phage display peptide library. These
peptides exhibited high afﬁnity binding to pAPN and inhibited cell
infection by TGEV completely (Ren et al., 2011). As a member of
group I coronaviruses, TGEV and PEDV have similar infection
characterizations and as such it is difﬁcult to differentiate these
pathogens based only upon clinical symptoms. Recent evidence
indicates that PEDV may also bind pAPN, a type II glycoprotein, as
a functional receptor (Li et al., 2007; Oh et al., 2003). Interestingly,
TGEV can be easily propagated in swine-originated cells such as ST
cells (Delmas et al., 1992; Hofmann and Wyler, 1988) whereas
PEDV is adapted and cultivated in African green monkey kidney
(Vero) cells rather swine cells. Given the stark similarities as well
as differences between TGEV and PEDV, we were interested in
evaluating the antiviral effects of the H, S and F peptides on cell
infection by PEDV.
We ﬁrst analyzed potential blockage of the pAPN-binding
peptides on Vero cell infection by PEDV. Plaque assays indicated
no signiﬁcant decrease in the infectivity of PDEV even though
prior studies showed that both anti-pAPN antibody and peptides
H, S or F were capable of inhibiting TGEV infection in vitro
(Ren et al., 2011a; Liu et al., 2009) if pre-incubated with TGEV
permissive cells. There were limited reports indicating that pAPN
may serve as a functional receptor of PEDV; however, studies
herein clearly demonstrated that pAPN is only expressed on the
surface of ST cells and is not present on Vero or MDCK cells. As
such, the inhibitory activities of peptide H were not due to binding
pAPN. Further, we showed that only pre-treatment with peptide H
inhibited infection by PEDV.
The PrV is a swine neurotropic herpesvirus with a DNA genome
that can be propagated in many cell lines including Vero cells.
Therefore, we used PrV as an additional control to further conﬁrm
and evaluate the inhibition speciﬁcity of the H peptide. Peptide H
did not prevent infection of pretreated TGEV or PrV suggesting its
inhibitory activity was speciﬁc and not due to virucidal effects of
amphipathic peptides. Clearly, peptide H was able to interact with
PEDV; however, it was unclear as to the mechanism of its antiviral
activity. As such, the binding characteristics between peptide H
(using the phage bearing the H peptide) and PEDV were further
examined by Western blot. Results clearly showed that phage H
reacted with a protein with a molecular mass of 220 kDa closely
approximating the molecular mass of the PEDV S protein. This
supposition was corroborated using antibody against the PEDV S
protein. In contrast, control phages bearing other peptides did not
show such reactivity. These results demonstrate that the peptide H
abrogates infectivity in part by binding to the PEDV S protein. This
is consistent with the function of the coronavirus S protein that
mediates cell infection. Further, cell post-treatment assays evalu-
ating the effects of each peptide on the replication of PEDV in vitro
Fig. 4. Quantiﬁcation of PEDV X-N gene. Total RNA was extracted from cell lysates
infected with PEDV (PFU¼5103/ml) pretreated with varying concentrations of
peptide H. The ΔCt values were measured from triplicate real-time RT-PCR data.
Relative ampliﬁcation of the PEDV X-N gene in the infected cells was normalized to
that of beta-actin and calculated using the 2ΔΔCt method. Peptide concentrations
1, 2, 3, 4, 5, and 6 are 0 μg/ml, 15.625 μg/ml, 31.25 μg/ml, 62.5 μg/ml, 125 μg/ml,
250 μg/ml, respectively; line 7 is cell control group. Displayed results are averages
of three independent experiments.
Fig. 5. Western blot analysis of phage H binding to PEDV. Sedimented PEDV was
subjected to SDS-PAGE followed by Western blot on nitrocellulose (NC) mem-
branes. The NC membranes were sliced and incubated with (1) phage H, (2) anti-
PEDV S polyclonal antibody, (3) M13 phage library, or control phages bearing the
peptides (4) SVSVGMKPSPRP or (5) MSCNDTLCLLPN. The membranes were succes-
sively incubated with anti-M13 polyclonal antibody and HRP-conjugated goat anti-
rabbit IgG. The protein bands were visualized using 3,3'-diaminodbenzidine.
The sizes of protein markers and location of the PEDV S protein are indicated.
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clearly demonstrated that the peptides do not interfere with the
intracellular replication of PEDV.
Our results showed that only peptide H and not peptides S or F
exhibited very high, dose-dependent inhibitory activity against
PEDV where as little as 1 μg/ml needed to achieve EC50. This was
conﬁrmed by real-time RT-PCR which showed decreasing amounts
of viral RNA in PEDV-infected cells. This corroborated the relation-
ship between the antiviral activity of peptide H and either
blockage of the viral attachment or entry into Vero cells. The
impact of peptide H on the entry of PEDV was ﬁrst investigated by
performing the cell post-treatment and co-incubation assays.
When PEDV was incubated with cells prior to treatment with
peptide H no signiﬁcant effects on PEDV infection were observed.
Similar results were seen when peptides, PEDV and the cells were
combined at the same time and co-incubated at 37 1C suggesting
that peptide H did not affect PEDV entry into the cell post-
adsorption. However, when PEDV was pre-incubated with peptide
H prior to incubation with Vero cells, peptide H blocked the
attachment of PEDV as determined from plaque assays and RT-
PCR analysis.
It became clear that peptide H did not interact with Vero cells
directly. Rather, it exhibits its inhibitory activity via the interplay
between the peptide H and PEDV. It is accepted that virus
adsorption occurs at 4 1C and internalization does not happen
until the temperature is raised to 37 1C (Baldick et al., 2010). Our
results clearly showed that the effects of peptide H occurred
during the incubation step at 4 1C rather than the 37 1C inter-
nalization step again targeting a speciﬁc interaction between
peptide H and PEDV that affects binding to the cell surface.
Both PEDV and TGEV are group I coronaviruses (Bridgen
et al., 1993) and propagate in Vero and ST cells, respectively; PrV
is a DNA virus that also propagates in Vero cells. As such, we
selected TGEV and PrV as control viruses to examine any speciﬁ-
city in the inhibitory activity of peptide H on cell infection by these
viruses. As expected, the results showed no signiﬁcant inhibitory
activity of peptide H on either TGEV or PrV infection. Further,
peptide H was not cytotoxic to either ST or Vero cells. These results
corroborate our hypothesis that peptide H functions in part, by
interacting with the S protein of PEDV and affecting the ability of
the virus to bind to the cell surface. Future studies will focus on
identifying the speciﬁc site of interaction of peptide H and
whether or not such a peptide can be used in vivo to abrogate or
attenuate PEDV infections.
Materials and methods
Cells and viruses
Swine testis (ST), Monkey kidney cell lines (Vero) and Madin-
Darby canine kidney (MDCK) cells were maintained in Dulbecco's
Modiﬁed Eagle Medium (DMEM) (Invitrogen, US) supplemented
with 10% fetal bovine serum, (FBS, GIBCO, US), 100 units/ml of
penicillin and 100 units/ml of streptomycin. All cells were pur-
chased from American Type Culture Collection (ATCC) and kept in
our laboratory. PEDV isolate HLJBY was propagated in Vero cells in
the presence of 10 μg/ml trypsin (GIBCO, US) (Ren et al., 2011b).
TGEV strain PUR46-MAD was propagated in ST cells (Ren et al.,
2008; Yin et al., 2010). Porcine pseudorabies virus (PrV) strain
Kaplan was propagated in Vero cells (Ren et al., 2011c).
Cytostatic assay
ST or Vero cells were seeded in 96-well plates at a density of
5104 cells/well and cultured in DMEM containing 10% FBS at
37 1C under 5% CO2 for 24 h followed by addition of serial dilutions
(62.5–1000 μg/ml) of the tested peptides. The cells were allowed
to grow for 48 h at 37 1C and proliferation was analyzed by
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) method. Brieﬂy, the mediumwas removed and 10 μl of MTT
solution (0.5 mg/ml, Invitrogen, US) was added and incubated at
37 1C for 4 h. Then 100 μl of dimethyl sulfoxide (DMSO) was added
and incubated for 15 min to solubilize the formazan crystals. Cell
survival rate was calculated as (OD490treatment)/(OD490control)
(Paeshuyse et al., 2006). The 50% cytostatic concentration (CC50)
was deﬁned as the concentration inhibiting the proliferation of
Fig. 6. Temperature shift and the effect of peptide H on cell infection by PEDV. (A) PEDV was treated with various concentrations of peptide H or with negative control
peptide F at 4 1C for 1 h then used to infect Vero cells (PFU¼5103/ml) at 4 1C. (B) PEDV (PFU¼5103/ml), peptides H or F, and Vero cells were co-incubated at 4 1C for 1 h,
washed, then shifted to 37 1C. (C) PEDV (PFU¼5103/ml), peptides, and Vero cells were co-incubated at 37 1C for 1 h then washed prior to assaying. (D) PEDV was treated
with various concentrations of peptides H or F at 4 1C or 37 1C for 1 h then used to infect Vero cells (PFU¼5103/ml) at 37 1C. Peptide concentrations 1, 2, 3, 4, and 5 are
250 μg/ml, 125 μg/ml, 62.5 μg/ml, 31.25 μg/ml, and 15.625 μg/ml, respectively. Anti-PEDV antibody dilutions 1, 2, 3, 4, and 5 are 1:4, 1:8, 1:16, 1:32 and 1:64, respectively.
Plaque assays were further performed at 72 h post-infection. Bars show the standard deviation from three independent assays.
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exponentially growing cells by 50%. Non-cytotoxic concentrations
of peptides (r CC50) were used for antiviral assays.
Antiviral assays
Three different treatment approaches were used to analyze the
antiviral action of the selected peptides H (HVTTTFAPPPPR), S
(SVVPSKATWGFA) and F (FKPSSPPSITLW) as previously deﬁned
(Kwon et al., 2010).
In the ﬁrst method, i.e., cell post-treatment assay, Vero cells
were grown in 24-well plates at a density of 5105 cells/well for
24 h. PEDV at a PFU (plaque-forming unit) of 5103/ml was
inoculated onto conﬂuent cells for 1 h followed by removal of
the medium and incubation of the infected cells with various non-
cytotoxic concentrations (r CC50) of peptides for 1 h at 37 1C. The
cells were then overlaid with 1% methylcellulose in DMEM and
incubated for 72 h at 37 1C followed by crystal violet staining and
plaque assays as previously described with modiﬁcations (Ren
et al., 2011a, 2011d). Brieﬂy, after the medium was removed, the
cells were ﬁxed with 4% formaldehyde in PBS for 1 h at room
temperature followed by staining with 1% crystal violet solution
for 20 min. The staining solution was removed, the cells were
washed with PBS and the plaques were counted. Decreases in
virus infectivity were calculated from the plaque assay as follows:
100 [1(treatment wells/control wells)]. Average EC50 values
(concentration inducing 50% inhibition of virus replication) were
calculated and the effectiveness of each peptide were expressed
using the selectivity index (SI) (SI¼CC50/EC50) (Paeshuyse et al.,
2006; Müller et al., 2007).
In the second method, i.e., cell pre-treatment assay, Vero cells
were ﬁrst grown in 24-well plates at a density of 5105 cells/well
for 24 h then treated with non-cytotoxic concentrations of peptide
for 1 h prior to incubation with virus. The peptides were removed
and the cells were washed twice with PBS. PEDV at a PFU of
5103/ml was inoculated onto the pre-treated Vero cells for 1 h.
After the virus was removed, the cells were overlaid with 1%
methylcellulose in DMEM and incubated for 72 h at 37 1C followed
by plaque assays.
In the third experiment i.e., virus pre-treatment, various con-
centrations of the peptides were mixed with PEDV (PFU¼5
103/ml) at 37 1C for 1 h prior to incubation with cells. Vero cells
were grown in 24-well plates at 5105 cells/well for 24 h then the
peptide/virus mixture was added to the cultured cells for 1 h. After
the mixture was removed and the cells washed with PBS, the cells
were overlaid with 1% methylcellulose in DMEM and cultured for
an additional 72 h at 37 1C followed by plaque assays as
described above.
In parallel, PEDV-neutralizing, rabbit antiserum serially-diluted
1:2 and PBS were used as positive and negative controls, respec-
tively, for the above-mentioned experiments. Each concentration
of the peptide and antibody was assayed in triplicate.
Immunoﬂuorescence assays to identify pAPN on cell lines from
different species
ST, Vero and MDCK cells were seed into the 24-well plates and
incubated at 37 1C for 24 h. Indirect immunoﬂuorescence assays
(IFA) were performed (Ren et al., 2011d; Baldick et al., 2010) with
modiﬁcation. The cells were washed twice with pre-chilled PBS
then ﬁxed with 4% paraformaldehyde in PBS for 30 min at room
temperature. Following two washes with PBS, they were quenched
with 0.1 M glycine for 5 min then blocked with 2% BSA (Sigma, US)
in PBS for 30 min. Samples were incubated for 1 h with anti-pAPN
polyclonal antibody (1:1500 in PBS) (Liu et al., 2009), washed
three times with PBS, and incubated with ﬂuorescein isothiocya-
nate (FITC) conjugated goat anti-rabbit IgG (1:1500 in PBS,
Zhongshan, China) for 1 h in the dark. The samples were washed
three times with PBS and the ﬂuorescence signals and phase
contrast images were detected by ﬂuorescence microscopy (Leica,
Wetzlar, Germany).
Virus speciﬁcity
Various concentrations of peptide H were incubated with the
TGEV, PEDV and PrV (PFU¼5103/ml) at 37 1C for 1 h then added
to conﬂuent Vero or ST cell monolayers for 1 h. The mixtures were
removed and the cultured cells washed twice with PBS then
incubated with 1% methylcellulose in DMEM for 72 h at 37 1C.
The cells were then stained with crystal violet staining and plaque
assays were performed as described above.
Semi-quantitative real-time reverse transcription-PCR
The effect of peptide H on PEDV infection of Vero cells was
conﬁrmed by semi-quantitative real-time reverse transcription
(RT-PCR) (Ren et al., 2011d). Vero cells in 6-well plates were
infected with PEDV (PFU¼5103/ml) pretreated with different
concentrations of peptide H at 37 1C for 1 h. The culture was
replaced with DMEM at 37 1C for 24 h then washed 3 times with
PBS. The virus-containing cultures were frozen and thawed three
times followed by addition of an equal volume of 20% polyethylene
glycol (PGE) 8000 at room temperature and incubation for 30 min.
The samples were centrifuged at 12,000 rpm for 5 min and the
pellets were re-suspended in RNase-free water. Total RNA was
extracted with a commercial kit (Fastgene, China) according to the
manufacturer's instructions. Reverse transcription was performed
in a total of 20 μl consisting of 5 μl total RNA (2.5 μg), 1 μl oligo dT,
1 μl dNTP (10 mM), 0.5 μl RNAse inhibitor, 7.5 μl sterile water, 1 μl
MLV, and 4 μl 5RT-PCR buffer. The mixture was incubated at
30 1C for 10 min, 42 1C for 60 min and 95 1C for 5 min. Real-time
PCR was performed using ABI PRISM 7500 real-time PCR machine
(Applied Biosystems, USA). The information regarding primers and
RT-PCR products is provided in Table 1. The real-time PCR mixture
included 0.5 μl (0.5 μg) of cDNA template, 10 μl of SYBR Taq
polymerase, 0.4 μl of ROX pge 2, 0.5 μl (10 pmol) of each primer,
and 8.1 μl of sterile water. The reactions were incubated at 95 1C
for 10 s followed by 40 cycles of 95 1C for 5 s and 60 1C for 34 s.
We examined virus RNA levels using primers that speciﬁcally
amplify a 244 bp fragment encompassing the 3' end of a small,
non-structural gene (X) and the 5' end of the PEDV-N gene
(Table 1). The expression of PEDV X-N in PEDV-infected Vero cells
was normalized to that of beta-actin and taken as 100% compared
to expression of the peptide H treatment group. Data analysis is
based on the measurement of the cycle threshold (Ct). The
difference in ΔCt (Ct sample fragment mean Ct value-beta-actin
fragment mean Ct value) was used as a measure of the relative
fragment with the 2ΔΔCt method in correlation to the ampliﬁca-
tion size of PEDV X-N fragment. For each experimental condition,
real-time PCR was conducted in quadruplicate and the resulting
average Ct values for the PEDV X-N fragment was used to quantify
viral load. The experiment was performed in triplicate.
Table 1
Information on primers and real-time RT-PCR products.
Primer pairs PCR product length (bp)
Sense 5' CACTGGTTGGGCTTTCTATGTC PEDVX-N
Antisense 5'TGTTAGTGGGTACAGCGTTGTT 244
Sense 5' GGCTCAGAGCAAGAGAGGTATCC β-actin
Antisense 5' GGTCTCAAACATGATCTGAGTCATCT 208
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Western blot analysis of peptide H binding to PEDV
The PEDV (1106 PFU/ml) was harvested from Vero cells and
clariﬁed by centrifugation at 1300g for 15 min followed by ultra-
centrifugation at 150,000g for 1.5 h to collect the virus. The pellets
were suspended in PBS, subjected to 10% SDS-PAGE then blotted to
a nitrocellulose (NC) membrane. The NC membranes were blocked
overnight at 4 1C with 5% non-fat dry milk in PBS. After three
washes with PBS, membranes were sliced and incubated with
phage H (11011 PFU), anti-PEDV S polyclonal antibody (1:1000
in PBS), M13 phage library (11011 PFU), and control phage
bearing either the peptides SVSVGMKPSPRP or MSCNDTLCLLPN.
The membranes were then washed with PBS and successively
incubated with anti-M13 polyclonal antibody (Abcam, 1:600 in
PBS) and horseradish peroxidase HRP-conjugated goat anti-rabbit
IgG (1:1500 in PBS) at room temperature for 1 h. Protein bands
were visualized using 3,3'-diaminodbenzidine (DAB, The Thermo
Scientiﬁc)
Temperature shift assays
To examine the effect of temperature on the binding of virus to
the cells, four experiments were performed. First, various con-
centrations of peptide H and control peptide F were incubated
with PEDV (PFU¼5103/ml) at 4 1C for 1 h then added to
conﬂuent Vero cells seeded in 24-well plates at 4 1C for 1 h
followed by infection at 37 1C for 72 h. Second, the peptides, PEDV
and Vero cells were co-incubated at 4 1C for 1 h, after which the
incubation temperature was raised to 37 1C for 72 h. Third, the
peptides, PEDV and Vero cells were co-incubated at 37 1C for 1 h
then assayed without prior incubation at 4 1C. Finally, peptides
were pre-incubated with PEDV at 4 1C or 37 1C for 1 h followed by
cell infection at 37 1C for 72 h. All experiments were terminated by
extensive washing of the cells and plaque assays to quantify the
infection.
Statistical analysis
Statistical analysis of the data was performed using SPSS 11.5
software; po0.05 and po0.01 were deﬁned as statistically
signiﬁcant and highly statistically signiﬁcant, respectively.
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